Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* LV less than 35%, as defined by echocardiogram, left ventriculogram, CMR, or gated single photon emission computed tomography (SPECT) studies~* Coronary anatomy suitable for revascularization~Exclusion Criteria:~* Failure to provide informed consent.~* Aortic valvular heart disease clearly indicating the need for aortic valve repair or replacement.~* Cardiogenic shock (within 72 hours of randomization), as defined by the need for intraaortic balloon support or the requirement for intravenous inotropic support.~* Plan for percutaneous intervention of CAD.~* Recent acute MI judged to be an important cause of left ventricular dysfunction.~* History of more than 1 prior coronary bypass operation.~* Noncardiac illness with a life expectancy of less than 3 years.~* Noncardiac illness imposing substantial operative mortality.~* Conditions/circumstances likely to lead to poor treatment adherence (eg, history of poor compliance, alcohol or drug dependency, psychiatric illness, no fixed abode).~* Previous heart, kidney, liver, or lung transplantation.~* Current participation in another clinical trial in which a patient is taking an investigational drug or receiving an investigational medical device.~MED Therapy Eligibility Criteria~* Absence of left main CAD as defined by an intraluminal stenosis of 50% or greater.~* Absence of CCS III angina or greater (angina markedly limiting ordinary activity).~SVR Eligibility Criterion~• Dominant akinesia or dyskinesia of the anterior left ventricular wall amenable to SVR.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- H01: Medication (Type: ACTIVE_COMPARATOR): Medical therapy alone to treat Coronary Artery Disease
- H01: Medication + CABG (Type: ACTIVE_COMPARATOR): Coronary artery bypass graft surgery (CABG) plus Medication to treat coronary artery disease
- H02: Medication+CABG (Type: ACTIVE_COMPARATOR): Coronary artery bypass graft surgery (CABG) plus Medication to treat coronary artery disease
- H02: Medication+CABG+SVR (Type: ACTIVE_COMPARATOR): CABG plus Medication and Surgical ventricular reconstruction (SVR)

Based on this trial design, predict the completion outcome and termination type (if applicable).